Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1985 3
1986 1
1988 1
1989 2
1990 1
1991 2
1992 3
1993 2
1994 1
1995 1
1996 5
1997 6
2001 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
A concomitant ATP-depleting strategy markedly enhances anticancer agent activity.
Martin DS, Spriggs D, Koutcher JA. Martin DS, et al. Apoptosis. 2001 Feb-Apr;6(1-2):125-31. doi: 10.1023/a:1009692631748. Apoptosis. 2001. PMID: 11321035 Review.
Potentiation of a three drug chemotherapy regimen by radiation.
Koutcher JA, Alfieri AA, Stolfi RL, Devitt ML, Colofiore JR, Nord LD, Martin DS. Koutcher JA, et al. Cancer Res. 1993 Aug 1;53(15):3518-23. Cancer Res. 1993. PMID: 8339257 Free article.
Radiation enhancement by biochemical modulation and 5-fluorouracil.
Koutcher JA, Alfieri AA, Thaler H, Matei C, Martin DS. Koutcher JA, et al. Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1145-52. doi: 10.1016/s0360-3016(97)00505-1. Int J Radiat Oncol Biol Phys. 1997. PMID: 9392557
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation.
Martin DS, Stolfi RL, Colofiore JR, Nord LD. Martin DS, et al. Anticancer Drugs. 1996 Aug;7(6):655-9. doi: 10.1097/00001813-199608000-00006. Anticancer Drugs. 1996. PMID: 8913434
In vitro and in vivo growth and casein gene expression of mouse mammary tumor epithelial cells in response to hormones.
Chou JL, Shen ZX, Tan IJ, Stolfi RL, Martin DS, Dikman SH, Waxman S. Chou JL, et al. Exp Cell Res. 1990 Feb;186(2):250-6. doi: 10.1016/0014-4827(90)90303-r. Exp Cell Res. 1990. PMID: 2153557
Failure of high-dose leucovorin to improve therapy with the maximally tolerated dose of 5-fluorouracil: a murine study with clinical relevance?
Martin DS, Stolfi RL, Colofiore JR. Martin DS, et al. J Natl Cancer Inst. 1988 Jun 1;80(7):496-501. doi: 10.1093/jnci/80.7.496. J Natl Cancer Inst. 1988. PMID: 3259266
Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro.
Street JC, Alfieri AA, Koutcher JA. Street JC, et al. Cancer Res. 1997 Sep 15;57(18):3956-62. Cancer Res. 1997. PMID: 9307279 Free article.
Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies.
Koutcher JA, Alfieri AA, Matei C, Meyer KL, Street JC, Martin DS. Koutcher JA, et al. Magn Reson Med. 1996 Dec;36(6):887-92. doi: 10.1002/mrm.1910360611. Magn Reson Med. 1996. PMID: 8946354
Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation.
Koutcher JA, Alfieri AA, Tsai JC, Matei C, Stolfi RL, Ballon D, Martin DS. Koutcher JA, et al. Cancer Invest. 1997;15(2):111-20. doi: 10.3109/07357909709115763. Cancer Invest. 1997. PMID: 9095206
13C and 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro.
Street JC, Mahmood U, Ballon D, Alfieri AA, Koutcher JA. Street JC, et al. J Biol Chem. 1996 Feb 23;271(8):4113-9. doi: 10.1074/jbc.271.8.4113. J Biol Chem. 1996. PMID: 8626749 Free article.
31 results
Jump to page